Pulling SEC filings + quote and writing the call…

MYOMO, INC.
Next earnings Aug 10, 2026 · consensus $-0.10 EPS, $10.5M rev
Last earnings +2.2% on 2026-05-07
Revenue grew 25.7% YoY; but unprofitable (net margin -38.1%).
MYOMO, INC. shows $40.9M in FY2025 revenue (+25.7% YoY), a -38.1% net margin, and -136.6% ROE.
Sources: SEC EDGAR (CIK 0001369290, latest 10-Q filed 2026-05-07) · EODHD · as of 6/26/2026, 1:55:31 AM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
The risks, catalysts, 12-month price target and the cited SEC figures behind this rating — with Pro.
Unlock with Pro€15/mo · cancel anytime
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $13.9M | $15.6M | $19.2M | $32.6M | $40.9M |
| Gross profit | $10.3M | $10.3M | $13.2M | $23.2M | $26.9M |
| Operating income | -$10.3M | -$10.7M | -$8.23M | -$6.21M | -$14.4M |
| Net income | -$10.4M | -$10.7M | -$8.15M | -$6.18M | -$15.6M |
| Diluted EPS | -$1.89 | -$1.52 | -$0.28 | -$0.16 | -$0.37 |
| Net margin | -74.9% | -68.9% | -42.3% | -19.0% | -38.1% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
1071 tracked peers · median
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
Last 90 days: 2 open-market buys · 0 sales
| 2026-06-12 | Kovelman Harry Chief Medical Officer | Tax | 10.4K @ $1.20 | $12.5K |
| 2026-06-12 | Mitchell Micah Chief Commercial Officer | Tax | 9.06K @ $1.20 | $10.9K |
| 2026-06-12 | HENRY DAVID A Chief Financial Officer | Tax | 11.0K | |
| 2026-06-08 | Mitchell Micah Chief Commercial Officer | Tax | 6.53K @ $1.33 | $8.68K |
| 2026-06-08 | Kovelman Harry Chief Medical Officer | Tax | 7.63K @ $1.33 | $10.2K |
| 2026-06-08 | HENRY DAVID A Chief Financial Officer | Tax | 10.1K | |
| 2026-06-05 | KIRK THOMAS F Director | Buy | 40.0K @ $1.27 | $50.8K |
| 2026-05-28 | KIRK THOMAS F Director | Buy | 25.0K @ $0.99 | $24.8K |
Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.